We are live on ! Find out more
BOCH

Blue Owl Capital Holdings Portfolio holdings

AUM $372M
1-Year Est. Return 78.25%
This Fund
S&P 500
This Quarter Est. Return
+5.38%
1 Year Est. Return
+78.25%
3 Year Est. Return
+112.77%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$418M
AUM Growth
+$289M
Cap. Flow
+$359M
Cap. Flow %
85.74%
Top 10 Hldgs %
73.32%
Holding
45
New
30
Increased
2
Reduced
1
Closed
2

Top Buys

Rank Stock Value
1
TOST icon
Toast
TOST
+$91.3M
2
PLRX icon
Pliant Therapeutics
PLRX
+$45.7M
3
CGEM icon
Cullinan Oncology
CGEM
+$30.3M
4
TRML
Tourmaline Bio
TRML
+$26.7M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$25.2M

Top Sells

Rank Stock Value
1
STWD icon
Starwood Property Trust
STWD
+$2.13M
2
GTLB icon
GitLab
GTLB
+$1.2M
3
FATH
Fathom Digital Manufacturing Corporation
FATH
+$217K

Sector Composition

Rank Sector Weight
1 Healthcare 66.67%
2 Financials 20.39%
3 Technology 11.87%
4 Industrials 0.19%
5 Real Estate 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
26
Dell
DELL
$293B
$2.68M 0.64%
+35,091
New +$2.48M
ORTX
27
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2.63M 0.63%
+1,599,660
New +$25.2M
IMVT icon
28
Immunovant
IMVT
$8.25B
$2.53M 0.6%
+60,000
New +$2.21M
BDTX icon
29
Black Diamond Therapeutics
BDTX
$112M
$1.95M 0.47%
+695,000
New +$1.63M
SGMT icon
30
Sagimet Biosciences
SGMT
$559M
$1.93M 0.46%
+355,377
New +$1.68M
ADCT icon
31
ADC Therapeutics
ADCT
$144M
$1.22M 0.29%
733,568
– –
GOCO
32
DELISTED
GoHealth
GOCO
$1.11M 0.27%
83,264
– –
BRZE icon
33
Braze
BRZE
$2.99B
$942K 0.23%
+17,726
New +$876K
BLND icon
34
Blend Labs
BLND
$386M
$922K 0.22%
361,587
– –
RLYB icon
35
Rallybio
RLYB
$85.8M
$837K 0.2%
+43,780
New +$1.07M
DM
36
DELISTED
Desktop Metal, Inc.
DM
$563K 0.13%
75,000
– –
FRLN
37
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$552K 0.13%
+86,654
New +$464K
ENGNW icon
38
enGene Therapeutics Warrants
ENGNW
$404K 0.1%
+475,077
New +$365K
UBER icon
39
Uber
UBER
$153B
$381K 0.09%
6,187
– –
MIRM icon
40
Mirum Pharmaceuticals
MIRM
$6.14B
$296K 0.07%
10,013
+5,229
+109% +$158K
FATH
41
DELISTED
Fathom Digital Manufacturing Corporation
FATH
$223K 0.05%
50,000
-50,000
-50% -$217K
DTIL icon
42
Precision BioSciences
DTIL
$207M
$221K 0.05%
+20,221
New +$218K
GTLB icon
43
GitLab
GTLB
$6.58B
– –
-26,590
Closed -$1.2M
STWD icon
44
Starwood Property Trust
STWD
$6.09B
– –
-109,991
Closed -$2.13M
PLMJW
45
DELISTED
Plum Acquisition Corp. III Warrant
PLMJW
$0 ﹤0.01%
666,666
– –
1
2

Similar funds

PC
Promethos Capital Boston, Massachusetts $372M AUM 23.19% 1-Year Est. Return
GIP
Gavilan Investment Partners Burlingame, California $372M AUM 6.04% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $372M AUM 14.96% 1-Year Est. Return
SAAM
Solus Alternative Asset Management Summit, New Jersey $372M AUM 45.33% 1-Year Est. Return
KP
Kiltearn Partners Edinburgh, United Kingdom $372M AUM 18.16% 1-Year Est. Return
TCM
Thomist Capital Management Houston, Texas $371M AUM 77.62% 1-Year Est. Return
PAA
Peregrine Asset Advisers Portland, Oregon $371M AUM 41.36% 1-Year Est. Return
JC
Joho Capital New York $373M AUM 18.89% 1-Year Est. Return

Blue Owl Capital Holdings's Q4 2023 Portfolio in Review

As of Q4 2023, Blue Owl Capital Holdings held 45 positions worth $418M, up 224% from $129M the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Blue Owl Capital Holdings deployed $359M of net new capital in Q4 2023, opening 30 new positions and adding to 2 existing holdings. Its largest new stake was Pliant Therapeutics: 3,004,199 shares worth $54.4M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, up from 0.62% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Fathom Digital Manufacturing Corporation, an estimated $217K trimmed.

  • Blue Owl Capital Holdings's largest Q4 2023 buy was Pliant Therapeutics: 3,004,199 shares worth $54.4M.
  • Blue Owl Capital Holdings added most to Toast in Q4 2023, an estimated $91.3M increase.
  • Blue Owl Capital Holdings's biggest Q4 2023 reduction was Fathom Digital Manufacturing Corporation, cutting an estimated $217K.
  • Blue Owl Capital Holdings fully exited Starwood Property Trust in Q4 2023, selling an estimated $2.13M.
  • Blue Owl Capital Holdings's ten largest holdings make up 73% of its $418M portfolio in Q4 2023.
  • Blue Owl Capital Holdings opened 30 new positions and closed 2 in Q4 2023.
  • Blue Owl Capital Holdings's portfolio value rose 224% quarter-over-quarter to $418M.

Based on Blue Owl Capital Holdings's 13F filing for Q4 2023, filed 15 Feb 2024.